VÉSALE BIOSCIENCE

News

Bacteriophages: Nature’s remedy for tackling superbugs and antimicrobial resistance

How bacteriophages offer a promising natural solution for tackling superbugs and antimicrobial resistance and outlines the Belgian Vésale Bioscience company’s efforts to become a pioneer in the development of innovative,…

Read more
2000 691 Vesale Bioscience
What sustainable alternative to antibiotic resistance in animal production ?

Namur (Belgium), 5 April 2023 Can phage therapy be a realistic alternative to fight antibiotic resistance in production animals? Join us on Wednesday, April 5, starting at 9:30 am at…

Read more
1200 1143 Vesale Bioscience
The European Innovation Council awards €1.8 million to Vésale Bioscience’s PhageDiag project

Namur (Belgium), 13 January 2023 Vésale Bioscience is developing innovative precision phage therapy solutions to treat bacterial infections resistant to antibiotics, and today announces that it has received a €1.8…

Read more
1920 1280 Vesale Bioscience
New team member
Vésale Bioscience for their MEDICAL FORGE Accelerator program 2023

Biosaxony, the Saxony’s Biotechnology, Medical Technology & Health Economy Cluster in Leipzig, has selected Vésale Bioscience for their MEDICAL FORGE Accelerator program 2023 (

Read more
1920 1280 Vesale Bioscience
Dr Vincent Grek joins the Vésale Bioscience team

CMO Dr Vincent Grek joins Vésale Bioscience as Chief Medical Officer He has a Strong Clinical Development Expertise in the biotech, nutrition and pharmaceutical industry (antibiotics, gene therapy, enzyme replacement…

Read more
1920 1280 Vesale Bioscience
Gunther Vanwezer
Gunther Vanwezer joins the Vésale Bioscience team

Gunther Vanwezer joins the Vésale Bioscience team as Chief Executive Officer. He hold a Master degree in Biochemical Engineering Technology from the University of Leuven (Belgium). He has over 25…

Read more
1920 1280 Vesale Bioscience
  • 1
  • 2